| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
T3, Free
Test Code34429
CPT Codes
84481
Preferred Specimen
1 mL serum
Minimum Volume
0.5 mL
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 28 days
Refrigerated: 7 days
Frozen: 28 days
Methodology
Immunoassay (IA)
Setup Schedule
A.M. Sets up 5 days a week.
Clinical Significance
The T3, Free (FT3) test measures serum triiodothyronine (T3) not bound to thyroid hormone-binding proteins (thyroid hormone-binding globulin [TBG], transthyretin, albumin). It is used, primarily in concert with measurement of thyroid-stimulating hormone (TSH, test code 899) and free T4 (FT4, test code 866), in the diagnosis and management of hyperthyroidism and to clarify thyroid hormone status in the presence of a possible thyroid hormone-binding protein abnormality.
The FT3 (or total T3) test is usually ordered following an abnormally low TSH result and/or a clinical picture suggestive of hyperthyroidism, particularly if the free T4 test (FT4, test code 899) result is not elevated. Up to 10% of patients with proven hyperthyroidism (due to Graves disease or an autonomously secreting thyroid nodule) may have an elevated FT3 but normal FT4 (T3 toxicosis), particularly early in the course of disease or as an early sign of relapse after treatment [1]. In contrast, there is limited utility for FT3 testing for suspected hypothyroidism as FT3 levels may not drop until well after both TSH and FT4 rise [2].
References
1. Carle A, et al. Eur J Endocrinol. 2013;169:537-545.
2. Garber JR, et al. Endocrine Pract. 2012;18:988-1028.
The FT3 (or total T3) test is usually ordered following an abnormally low TSH result and/or a clinical picture suggestive of hyperthyroidism, particularly if the free T4 test (FT4, test code 899) result is not elevated. Up to 10% of patients with proven hyperthyroidism (due to Graves disease or an autonomously secreting thyroid nodule) may have an elevated FT3 but normal FT4 (T3 toxicosis), particularly early in the course of disease or as an early sign of relapse after treatment [1]. In contrast, there is limited utility for FT3 testing for suspected hypothyroidism as FT3 levels may not drop until well after both TSH and FT4 rise [2].
References
1. Carle A, et al. Eur J Endocrinol. 2013;169:537-545.
2. Garber JR, et al. Endocrine Pract. 2012;18:988-1028.
